New Stock News | Shandong Linuo Pharmaceutical Packaging (301188.SZ) Files with the Hong Kong Stock Exchange
According to a disclosure by the Hong Kong Stock Exchange on September 28, Shandong Linuo Pharmaceutical Packaging Co., Ltd. (referred to as Linuo Pharmaceutical Packaging, 301188.SZ) has submitted an application for listing to the Main Board of the Hong Kong Stock Exchange, with China Merchants Securities International and Ligao Financial Group as its joint sponsors.
According to a disclosure by the Hong Kong Stock Exchange on September 28, Shandong Linuo Pharmaceutical Packaging Co., Ltd. (referred to as: Shandong Linuo Pharmaceutical Packaging, 301188.SZ) has submitted an application for listing to the Main Board of the Hong Kong Stock Exchange, with CMSC International and Ligao Financial Group as its joint sponsors. The prospectus shows that Shandong Linuo Pharmaceutical Packaging is a well-known borosilicate specialty glass supplier in China. The company focuses on the development, manufacturing, and sales of borosilicate pharmaceutical glass packaging and daily-use heat-resistant glass, with products applied in the pharmaceutical, biotechnology, food and beverage, and daily household industries. Leveraging the company's R&D capabilities in furnace design and glass melting technology, Shandong Linuo Pharmaceutical Packaging developed China's first hexagonal stepped all-electric glass melting furnace.
Related Articles

MEGA GENOMICS (06667) repurchased 148,800 shares for HK$1.0691 million on October 8.

Jiangsu Lopal Tech. Group (603906.SH) Subsidiary Signs Lithium Iron Phosphate Cathode Material Sales Agreement with Jiyao Tongxing

GEEKPLUS-W (02590) repurchased 150,000 shares for HK$1.0482 million on October 8.
MEGA GENOMICS (06667) repurchased 148,800 shares for HK$1.0691 million on October 8.

Jiangsu Lopal Tech. Group (603906.SH) Subsidiary Signs Lithium Iron Phosphate Cathode Material Sales Agreement with Jiyao Tongxing

GEEKPLUS-W (02590) repurchased 150,000 shares for HK$1.0482 million on October 8.






